Frequency of polycystic ovarian syndrome among patients presenting with acne

Sadia Jabeen, Faria Asad, Zahida Rani, Khawar Khurshid, Sabrina Suhail Pal


Objective To determine the frequency of polycystic ovarian syndrome among patients presenting with acne.


Methods 200 female patients having grade I-IV acne vulgaris, fulfilling inclusion and exclusion criteria were enrolled in the study after taking informed consent. They were screened for the presence of polycystic ovarian syndrome (PCOS) by using Rotterdam criteria 2003.


Results Out of 200 females with acne vulgaris, 92 (46%) had polycystic ovarian syndrome. Age of the patients ranged from 14-40 years. In grade I to IV acne 6%, 16%, 12% and 12% patients had PCOS, respectively.


Conclusion Polycystic ovarian syndrome is not uncommon in patients with acne vulgaris. However it is not related to the severity of acne.



Acne vulgaris, polycystic ovarian syndrome

Full Text:



Rathi SK. Acne Vulgaris Treatment: The current scenario. Indian J Dermatol. 2011;58:7-13.

Suh DH, Kim BY, Min SU, Lee DH, Yoon MY, Kim NI et al. A multicentre epidemiological study of acne vulgaris in Korea. Int J Dermatol. 2011;50:673-81.

Layton AM. Disorder of Sebaceous Gland. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook's Textbook of Dermatology. 8th edn. Oxford: Blackwell Science; 2010. P. 42.17-70.

Moura HH, Costa DL, Bagatin E, Sodre` CT, Manela-Azulay M. Polycystic ovary syndrome: a dermatologic approach. An Brass Dermatol. 2011;86:111-9.

Makrantonaki E, Ganceviciene R, Zouboulis C. An update on the role of the sebaceous gland in the pathogenesis of acne. Dermatol Endocrinol. 2011;3:41-9.

Chen W, Obermayer-Pietsch B, Hong JB, Melnik B, Yamasaki O, Dessinioti C et al. Acne associated syndromes: models for better understanding of acne pathogenesis. J Eur Acad Dermatol Venereol. 2011;25:637-46.

Azziz R, Carmina E, Kandarakis DE, Morreale EF, Futterweit W, Janssen EO et al. Criteria for defining PCOS as a predominantly hyperandrogenic syndrome: An androgen excess society guidelines. J Clin Endocrinol Metab. 2006;91:423-7.

Lo JC, Feigenbaum SL, Yang J, Pressman AR, Selby JV, Go AS. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:1357-63.

Zandi S, Farajzadeh S, Safari H. Prevalence of polycystic ovary syndrome in women with acne: hormone profiles and clinical findings. J Pak Assoc Dermatol. 2016;20:194-8.

The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19-25.

Adityan B, Kumari R, Thappa DM. Scoring systems in acne vulgaris. Indian J Dermatol Venereol Leprol. 2009;75:323-6.

Begum S, Hossain MZ, Rahman MF, Banu LA. Polycystic ovarian syndrome in women with acne. J Pak Assoc Dermatol. 2012;22:24-9.

Fraser IS, Kovacs G. Current recommendations for the diagnostic evaluation and follow-up of patients presenting with symptomatic polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18:813-23.

Cunliffe WJ, Holland DB, Jeremy A. Comedone formation: etiology, clinical presentation, and treatment. Clin Dermatol. 2004;22:367-74.

Maluki AH. The frequency of polycystic ovary syndrome in females with resistant acne vulgaris. J Cosmet Dermatol. 2010;9:142-8.

Timpatanapong P, Rojanasakul A. Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne. J Dermatol. 1997;24:223.

Bunker CB, Newton JA, Kilborn J, Patel A, Conway GS, Jacobs HS et al. Most women with acne have polycystic ovaries. Br J Dermatol. 1989;121:675-80.

Peserico A, Angeloni G, Bertoli P, Marini A, Piva G, Panciera A et al. Prevalence of polycystic ovaries in women with acne. Arch Dermatol Res. 1989;281:502-3.

Cibula D, Hill M, Vohradnikova O, Kuzel D, Fanta M, Zivny J. The role of androgens in determining acne severity in adult women. Br J Dermatol. 2000;143:399-404.


  • There are currently no refbacks.

ISSN: 1560-9014